Alexandra Charrow is a Dermatology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 92 publications with 2,256 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
221 Longwood Ave
Boston, MA 021155804
Telephone
617-732-4918Registry record last updated 21 Jun 2019.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year20259 payments
- UCB, Inc.Program year20252 payments
- UCB, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
30%Interleukin-17A Antagonist10%Cosentyx Sensoready (2 Pens)100%Part D≥11 patientsPhosphodiesterase 4 Inhibitor4.8%Otezla100%Part D<11 patients+ 6 more classes in this area
Anti-infectives
29.8%Tetracycline-class Drug9.8%Doxycycline Monohydrate70%Doxycycline Hyclate18%Minocycline Hcl13%Part D<11 patientsAzole Antifungal7.8%Ketoconazole83%Fluconazole17%Part D<11 patients+ 4 more classes in this area
Dermatology
13.3%Interleukin-4 Receptor alpha Antagonist6.3%Dupixent Syringe52%Dupixent Pen48%Part D<11 patientsCorticosteroid5.3%Triamcinolone Acetonide100%Part D≥39 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Glucagon-like peptide-1 receptor agonists in the adjunctive treatment of patients with hidradenitis suppurativa: A systematic review
Journal of the American Academy of Dermatology
2025 - Safety and efficacy of biologics in patients with Down syndrome and hidradenitis suppurativa: a retrospective cohort study
Clinical and Experimental Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”